FRIENDSWOOD, Texas — August 21, 2025 — Leads & Copy — Castle Biosciences, Inc. (Nasdaq: CSTL) will present a company overview at Baird’s 2025 Global Healthcare Conference on Wednesday, Sept. 10, 2025, at 10:15 a.m. Eastern time. A live audio webcast will be available on the company’s website. A replay will follow the live broadcast.
Castle will also attend the Wells Fargo 20th Annual Healthcare Conference on Sept. 4, 2025, and the 9th Annual Lake Street Best Ideas Growth (BIG9) Conference on Sept. 11, 2025. Meeting requests can be made through Wells Fargo and Lake Street Capital Markets.
Castle Biosciences (Nasdaq: CSTL) develops innovative tests to guide patient care, focusing on skin cancers, Barrett’s esophagus, and uveal melanoma, with ongoing R&D for other diseases, including a test for systemic therapy selection in moderate-to-severe atopic dermatitis.
Investor Contact: Camilla Zuckero, czuckero@castlebiosciences.com
Media Contact: Allison Marshall, amarshall@castlebiosciences.com
Source: Castle Biosciences Inc.
